Comment on

• Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

  Liu CH, Huang CF, Liu CJ, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Chen SI, Lin JW, Yang SS, Su TH, Yang HC, Chen PJ, Chen DS, Chuang WL, Yu ML, Kao JH. Liu CH, et al. Ann Intern Med. 2013 Dec 3;159(11):729-38. doi: 10.7326/0003-4819-159-11-201312030-00005. Ann Intern Med. 2013. PMID: 24297189 Clinical Trial.
• Triple therapy for hepatitis C virus infection in patients receiving hemodialysis.

  Lemoinne S, Barrou B, Thabut D. Lemoinne S, et al. Ann Intern Med. 2014 Apr 15;160(8):581. doi: 10.7326/L14-5008-3. Ann Intern Med. 2014. PMID: 24733207 No abstract available.